Development of a reliable remote-controlled synthesis of β-[11C]-5-hydroxy-L-tryptophan on a Zymark robotic system

Precise staging of neuroendocrine tumors (NET) using positron emission tomography (PET) tracers visualizing their specific metabolic activity is of interest. Besides [18F]FDOPA, staging NET with carbon‐11 labeled 5‐hydroxytryptophan (5‐HTP) is reported in recent literature. We implemented the multi‐...

Full description

Saved in:
Bibliographic Details
Published in:Journal of labelled compounds & radiopharmaceuticals Vol. 49; no. 10; pp. 889 - 895
Main Authors: Neels, O. C., Jager, P. L., Koopmans, K. P., Eriks, E., de Vries, E. G. E., Kema, I. P., Elsinga, P. H.
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Ltd 01-09-2006
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Precise staging of neuroendocrine tumors (NET) using positron emission tomography (PET) tracers visualizing their specific metabolic activity is of interest. Besides [18F]FDOPA, staging NET with carbon‐11 labeled 5‐hydroxytryptophan (5‐HTP) is reported in recent literature. We implemented the multi‐enzymatic synthesis of enantiomerically pure [11C]‐L‐5‐HTP on a Zymark robotic system to compare both tracers in patient studies. [11C]‐5‐HTP can be synthesized in up to 24% radiochemical yields (EOB). Average specific activity is 44 000 GBq/mmol in ca. 50 min from [11C]methyl iodide in radiochemical purities >99 %. The synthesis of 5‐HTP is difficult due to its multi‐enzymatic reaction steps but typical yields can be achieved of ca. 400 MBq. [11C]‐5‐HTP is now reliably used in ongoing studies for staging NET. Copyright © 2006 John Wiley & Sons, Ltd.
Bibliography:Dutch Cancer Society - No. 2003-2936
ark:/67375/WNG-649SH1TJ-K
ArticleID:JLCR1110
istex:1FFEAB13457EDF66AFAF59CEC3FE414A25348727
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0362-4803
1099-1344
DOI:10.1002/jlcr.1110